Patent
Formulation for the controlled release of one or several substances in the digestive tract of a mammal
| العنوان: | Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
|---|---|
| Patent Number: | 10799,460 |
| تاريخ النشر: | October 13, 2020 |
| Appl. No: | 14/343393 |
| Application Filed: | September 07, 2012 |
| مستخلص: | The present invention relates to a formulation for the controlled release of active ingredients after the passage of the ileo-cecal-valve, comprising one or more active ingredients or one or more active ingredient containing cores (W), enveloped by one or more envelopments (C), which are dissoluble or permeable above an individual defined pH value and are dissoluble or permeable below another individual defined pH value, again enveloped by an envelopment (E), which is dissoluble or permeable above still another individual defined pH value. |
| Inventors: | Saur-Brosch, Roland (Heidelberg, DE) |
| Claim: | 1. A formulation for the controlled release of one or more active ingredients in the large intestine of a mammal, characterized in that one or more active ingredients are enveloped with an Enteric layer and one or more individual further layers, wherein said one or more individual further layers are enveloped by said enteric layer, and wherein multiple further layers are enveloped by each other, and wherein each of said individual further layers is characterized by an individual defined lower pH threshold value and an individual defined upper pH threshold value and wherein each of said individual further layers is substantially or completely dissolvable or permeable in aqueous solutions with a pH value below that layer's own defined lower pH threshold value, and wherein each of said further layers is also substantially or completely dissolvable or permeable in aqueous solutions with a pH value above that layer's own defined upper pH threshold value, and wherein each of said further layers is neither substantially or completely dissolvable nor permeable in aqueous solutions with a pH value between that layer's own defined lower pH threshold value and that layer's own defined upper pH threshold value, and wherein said Enteric layer is characterized by a defined last pH threshold value, said defined last pH threshold value also being referred to as the defined upper pH threshold value of said Enteric layer, and wherein said Enteric layer is substantially or completely dissolvable or permeable in aqueous solutions only with a pH value above said defined last pH threshold value and wherein the defined last pH threshold value lies between 2 and 9, and the individual defined lower pH threshold value of each one of said one or more individual further layers is lower than the individual defined upper pH threshold value of that particular individual further layer itself, and that the defined upper pH threshold value of each single one of any of said layers that is enveloping one of said further layers lies between the individual defined lower and the individual defined upper pH threshold value of that further layer being enveloped by said single one layer. |
| Claim: | 2. A formulation according to claim 1 , characterized in that the one or more active ingredients are enveloped with a Caecal layer, and the one or more active ingredients being enveloped with said Caecal layer, as well as said Caecal layer, are enveloped by the one or more further layers and the Enteric layer according to claim 1 , wherein said Caecal layer is characterized by a defined lower pH threshold value, said defined lower pH threshold value of said Caecal layer also being referred to as the defined first pH threshold value, and wherein said Caecal layer is substantially or completely dissolvable or permeable in aqueous solutions only with a pH value below said defined lower pH threshold value of said Caecal layer and wherein the defined lower pH threshold value of the Caecal layer lies between 2 and 9, and that the defined upper pH threshold value of the further layer that is enveloping said Caecal layer lies above the defined lower pH threshold value of said Caecal layer. |
| Claim: | 3. A formulation according to claim 1 , characterized in that at least one of said further layers comprises two different polymers, wherein at least one of said two different polymers is substantially or completely dissolvable or permeable in aqueous solutions with a pH value above a certain pH value and wherein at least another one of said two different polymers is substantially or completely dissolvable or permeable in aqueous solutions with a pH value below a certain pH value. |
| Claim: | 4. A formulation according to claim 2 , characterized in that at least one of said further layers comprises two different polymers, wherein at least one of said two different polymers is substantially or completely dissolvable or permeable in aqueous solutions with a pH value above a certain pH value and wherein at least another one of said two different polymers is substantially or completely dissolvable or permeable in aqueous solutions with a pH value below a certain pH value. |
| Claim: | 5. A formulation according to claim 1 , characterized in that at least one of said further layers comprises a polymer, wherein said polymer is substantially or completely dissolvable or permeable in aqueous solutions with a pH value below a certain range and wherein said polymer is also substantially or completely dissolvable or permeable in aqueous solutions with a pH value above a certain range but wherein said polymer is neither substantially or completely dissolvable nor permeable in aqueous solutions with a pH value within said certain range. |
| Claim: | 6. A formulation according to claim 2 , characterized in that at least one of said further layers comprises a polymer, wherein said polymer is substantially or completely dissolvable or permeable in aqueous solutions with a pH value below a certain range and wherein said polymer is also substantially or completely dissolvable or permeable in aqueous solutions with a pH value above a certain range but wherein said polymer is neither substantially or completely dissolvable nor permeable in aqueous solutions with a pH value within said certain range. |
| Claim: | 7. A formulation according to claim 5 , characterized in that at least one of said further layers comprises a Chitosan, wherein said chitosan comprises succinic acid groups. |
| Claim: | 8. A formulation according to claim 6 , characterized in that at least one of said further layers comprises a Chitosan, wherein said chitosan comprises succinic acid groups. |
| Claim: | 9. A formulation according to claim 5 , characterized in that at least one of said further layers comprises a Chitosan, wherein said chitosan comprises chlorogenic acid groups. |
| Claim: | 10. A formulation according to claim 6 , characterized in that at least one of said further layers comprises a Chitosan, wherein said chitosan comprises chlorogenic acid groups. |
| Claim: | 11. A formulation for the controlled release of one or more active ingredients in the large intestine of a mammal, characterized in that one or more active ingredients are enveloped with a Caecal layer, an Enteric layer and one or more individual amphoteric layers, wherein said Caecal layer is enveloped by said one or more individual amphoteric layers and wherein said one or more individual amphoteric layers are enveloped by said enteric layer, and wherein multiple amphoteric layers are enveloped by each other, and wherein said Caecal layer is characterized by a defined lower pH threshold value, said defined lower pH threshold value of said Caecal layer also being referred to as the defined first pH threshold value, and wherein each of said individual amphoteric layers is characterized by an individual defined lower pH threshold value and an individual defined upper pH threshold value, and wherein said Enteric layer is characterized by a defined last pH threshold value, said defined last pH threshold value also being referred to as the defined upper pH threshold value of said Enteric layer, and wherein said Caecal layer is substantially or completely dissolvable or permeable in aqueous solutions only with a pH value below said defined first pH threshold value, and wherein each of said individual amphoteric layers is substantially or completely dissolvable or permeable in aqueous solutions with a pH value below that layer's own defined lower pH threshold value, and wherein each of said amphoteric layers is also substantially or completely dissolvable or permeable in aqueous solutions with a pH value above that layer's own defined upper pH threshold value, and wherein each of said amphoteric layers is neither substantially or completely dissolvable nor permeable in aqueous solutions with a pH value between that layer's own defined lower pH threshold value and that layer's own defined upper pH threshold value, and wherein said Enteric layer is substantially or completely dissolvable or permeable in aqueous solutions only with a pH value above said defined last pH threshold value, and wherein the defined first pH threshold value lies between pH 2 and pH 9, and wherein the defined last pH threshold value lies between pH 2 and pH 9, and wherein the individual defined lower pH threshold value of each one of said one or more individual amphoteric layers is lower than the individual defined upper pH threshold value of that particular individual amphoteric layer itself, and wherein the defined upper pH threshold value of each single one of any of said layers that is enveloping another one of said layers lies above the individual defined lower pH threshold value of the layer being enveloped by said single one layer and wherein the defined upper p threshold value of each single one of any of said layers that is enveloping one of said amphoteric layers lies below the individual defined upper pH threshold value of that amphoteric layer being enveloped by said single one layer. |
| Claim: | 12. A formulation for the controlled release of one or more active ingredients in the large intestine of a mammal, characterized in that one or more active ingredients are enveloped with an Enteric layer and an amphoteric layer, wherein said amphoteric layer is enveloped by said enteric layer, and wherein said amphoteric layer is characterized by a defined lower pH threshold value and a defined upper pH threshold value, and wherein said Enteric layer is characterized by a defined last pH threshold value, said defined last pH threshold value also being referred to as the defined upper pH threshold value of said Enteric layer, and wherein said amphoteric layers is substantially or completely dissolvable or permeable in aqueous solutions with a pH value below that layer's own defined lower pH threshold value, and wherein said amphoteric layer is also substantially or completely dissolvable or permeable in aqueous solutions with a pH value above that layer's own defined upper pH threshold value, and wherein said amphoteric layer is neither substantially or completely dissolvable nor permeable in aqueous solutions with a pH value between that layer's own defined lower pH threshold value and that layer's own defined upper pH threshold value, and wherein said Enteric layer is substantially or completely dissolvable or permeable in aqueous solutions only with a pH value above said defined last pH threshold value, and wherein the defined last pH threshold value lies between pH 2 and pH 9, and wherein the individual defined lower pH threshold value of said amphoteric layer is lower than the individual defined upper pH threshold value of that amphoteric layer itself, and wherein the defined upper pH threshold value of said Enteric layer lies between the individual defined lower and the individual defined upper pH threshold value of said amphoteric layer. |
| Claim: | 13. A formulation for the controlled release of one or more active ingredients in the large intestine of a mammal, characterized in that one or more active ingredients are enveloped with an Enteric layer and one or more individual amphoteric layers, wherein said one or more individual amphoteric layers are enveloped by said enteric layer, and wherein multiple amphoteric layers are enveloped by each other, and wherein each of said individual amphoteric layers is characterized by an individual defined lower pH threshold value and an individual defined upper pH threshold value and wherein each of said individual amphoteric layers is dissolvable or permeable in aqueous solutions with a pH value below that layer's own defined lower pH threshold value, and wherein each of said amphoteric layers is also dissolvable or permeable in aqueous solutions with a pH value above that layer's own defined upper pH threshold value, and wherein each of said amphoteric layers is neither dissolvable nor permeable in aqueous solutions with a pH value between that layer's own defined lower pH threshold value and that layer's own defined upper pH threshold value, and wherein said Enteric layer is characterized by a defined last pH threshold value, said defined last pH threshold value also being referred to as the defined upper pH threshold value of said Enteric layer, and wherein said Enteric layer is dissolvable or permeable in aqueous solutions only with a pH value above said defined last pH threshold value and wherein the defined last pH threshold value lies between 2 and 9, and the individual defined lower pH threshold value of each one of said one or more individual amphoteric layers is lower than the individual defined upper pH threshold value of that particular individual amphoteric layer itself, and that the defined upper pH threshold value each single one of any of said layers that is enveloping one of said amphoteric layers lies between the individual defined lower and the individual defined upper pH threshold value of that amphoteric layer being enveloped by said single one layer. |
| Claim: | 14. A formulation according to claim 13 , characterized in that the one or more active ingredients are enveloped with a Caecal layer, and the one or more active ingredients being enveloped with said Caecal layer, as well as said Caecal layer, are enveloped by the one or more amphoteric layers and the Enteric layer according to claim 13 , wherein said Caecal layer is characterized by a defined lower pH threshold value, said defined lower pH threshold value of said Caecal layer also being referred to as the defined first pH threshold value, and wherein said Caecal layer is dissolvable or permeable in aqueous solutions only with a pH value below said defined lower pH threshold value of said Caecal layer and wherein the defined lower pH threshold value of the Caecal layer lies between 2 and 9, and that the defined upper pH threshold value of the amphoteric layer that is enveloping said Caecal layer lies above the defined lower pH threshold value of said Caecal layer. |
| Claim: | 15. A formulation according to claim 13 , characterized in that at least one of said amphoteric layers comprises two different polymers, wherein at least one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value above a certain pH value and wherein at least another one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value below a certain pH value. |
| Claim: | 16. A formulation according to claim 14 , characterized in that at least one of said amphoteric layers comprises two different polymers, wherein at least one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value above a certain pH value and wherein at least another one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value below a certain pH value. |
| Claim: | 17. A formulation according to claim 13 , characterized in that at least one of said amphoteric layers comprises a polymer, wherein said polymer is dissolvable or permeable in aqueous solutions with a pH value below a certain range and wherein said polymer is also dissolvable or permeable in aqueous solutions with a pH value above a certain range but wherein said polymer is neither dissolvable nor permeable in aqueous solutions with a pH value within said certain range. |
| Claim: | 18. A formulation according to claim 14 , characterized in that at least one of said amphoteric layers comprises a polymer, wherein said polymer is dissolvable or permeable in aqueous solutions with a pH value below a certain range and wherein said polymer is also dissolvable or permeable in aqueous solutions with a pH value above a certain range but wherein said polymer is neither dissolvable nor permeable in aqueous solutions with a pH value within said certain range. |
| Claim: | 19. A formulation according to claim 17 , characterized in that at least one of said amphoteric layers comprises a Chitosan, wherein said chitosan comprises succinic acid groups. |
| Claim: | 20. A formulation according to claim 18 , characterized in that at least one of said amphoteric layers comprises a Chitosan, wherein said chitosan comprises succinic acid groups. |
| Claim: | 21. A formulation according to claim 15 , characterized in that each of said layers is considered dissolvable if it is at least dissolvable to such an extent that is necessary in order to let the surrounding aqueous solution come into contact with the next layer that is arranged further inside. |
| Claim: | 22. A formulation according to claim 16 , characterized in that each of said layers is considered dissolvable if it is at least dissolvable to such an extent that is necessary in order to let the surrounding aqueous solution come into contact with the next layer that is arranged further inside. |
| Claim: | 23. A formulation according to claim 17 , characterized in that each of said layers is considered dissolvable if it is at least dissolvable to such an extent that is necessary in order to let the surrounding aqueous solution come into contact with the next layer that is arranged further inside. |
| Claim: | 24. A formulation according to claim 18 , characterized in that each of said layers is considered dissolvable if it is at least dissolvable to such an extent that is necessary in order to let the surrounding aqueous solution come into contact with the next layer that is arranged further inside. |
| Claim: | 25. A formulation according to claim 13 , characterized in that at least one of said amphoteric layers comprises two different polymers, wherein at least one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value above a certain pH value, being about the same as the defined upper pH threshold value of said at least one amphoteric layer comprising said at least one polymer and wherein at least another one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value below a certain pH value, being about the same as the defined lower pH threshold value of said at least one amphoteric layer comprising said at least another one polymer. |
| Claim: | 26. A formulation according to claim 14 , characterized in that at least one of said amphoteric layers comprises two different polymers, wherein at least one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value above a certain pH value, being about the same as the defined upper pH threshold value of said at least one amphoteric layer comprising said at least one polymer and wherein at least another one of said two different polymers is dissolvable or permeable in aqueous solutions with a pH value below a certain pH value, being about the same as the defined lower pH threshold value of said at least one amphoteric layer comprising said at least another one polymer. |
| Claim: | 27. A formulation according to claim 25 , characterized in that said two different polymers are arranged effectively parallel, wherein effectively parallel means that as soon as one of said two polymers becomes dissolved, the surrounding solution can pass the other one of said two polymers and comes into contact with the next layer that is arranged further inside or with the one or more active ingredients. |
| Claim: | 28. A formulation according to claim 26 , characterized in that said two different polymers are arranged effectively parallel, wherein effectively parallel means that as soon as one of said two polymers becomes dissolved, the surrounding solution can pass the other one of said two polymers and comes into contact with the next layer that is arranged further inside or with the one or more active ingredients. |
| Claim: | 29. A formulation according to claim 13 , characterized in that the formulation comprises two amphoteric layers, wherein the Enteric layer envelops the second amphoteric layer and the second amphoteric layer envelops the first amphoteric layer and wherein the defined lower pH threshold value of the second amphoteric layer is lower than the defined lower pH threshold value of the first amphoteric layer and wherein the defined upper pH threshold value of the second amphoteric layer lies between the defined lower pH threshold value and the defined upper pH threshold value of the first amphoteric layer. |
| Patent References Cited: | 6506407 January 2003 Watanabe 7288532 October 2007 Payne 2005/0037077 February 2005 Legrand 2006/0127484 June 2006 Speirs 2006/0188563 August 2006 Shuji 2009/0022786 January 2009 Lee 2009/0263340 October 2009 Ille-Boehler 2010/0209520 August 2010 Kubo 2012/0141584 June 2012 Chauhan 2014/0322316 October 2014 Saur-Brosch 1204363 November 1965 3812799 October 1989 69109557 September 1995 69225979 December 1998 19932603 January 2001 69425453 April 2001 69522729 July 2002 69619668 October 2002 69624047 August 2003 69922394 December 2005 69535432 December 2007 60035412 March 2008 1607087 December 2005 1496870 September 2009 2336865 October 2008 95/30422 November 1995 96/36321 November 1996 2004/004696 January 2004 2006/102446 September 2006 2007/006353 January 2007 |
| Other References: | Seipmann et al. (Pharmaceutical Research, 1999, 16(11):1748-1756). cited by examiner Aideh et al.(Arch. Pharm. Pharm. Med. Chem. 1999;332:103-107). (Year: 1999). cited by examiner Chauhan, Ch. S. et al, Formulation and evaluation of Prednisolone tablet for colon targeted drug delivery system, J. Chem. Pharm. Res., 2010, vol. 2, No. 4, pp. 993-998, ISSN 0975-7384. cited by applicant Sauer, D. et al, Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55, Pharmaceutical Development and Technology, 2009; 14(6): 632-641. cited by applicant Ibekwe, V. C. et al., A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery, International Journal of Pharmaceutics, 2006, vol. 308, pp. 52-60, ISSN 0378-5173. cited by applicant |
| Primary Examiner: | Arnold, Ernst V |
| رقم الانضمام: | edspgr.10799460 |
| قاعدة البيانات: | USPTO Patent Grants |
| الوصف غير متاح. |